Essential role of NADPH oxidase-dependent reactive oxygen species generation in regulating MicroRNA-21 expression and function in prostate cancer

Antioxidants and Redox Signaling

Volumn 19, Issue 16, 2013, Pages 1863-1876

  Jajoo, Sarvesh ^a   Mukherjea, Debashree ^a   Kaur, Tejbeer ^a   Sheehan, Kelly E ^a   Sheth, Sandeep ^a   Borse, Vikrant ^a   Rybak, Leonard P ^a   Ramkumar, Vickram ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MASPIN; MEMBRANE PROTEIN; MICRORNA 21; PROGRAMMED CELL DEATH 4; PROTEIN KINASE B; PROTEIN P47; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; MICRORNA; MIRN21 MICRORNA, HUMAN; PDCD4 PROTEIN, HUMAN; RNA BINDING PROTEIN; SERINE PROTEINASE INHIBITOR; SERPIN-B5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; SCID MOUSE; TUMOR CELL CULTURE; TUMOR INVASION;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, SCID; MICRORNAS; NADPH OXIDASE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; SERPINS; TUMOR CELLS, CULTURED;

EID: 84888624144     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4820     Document Type: Article

References (60)

1. Abraham S, Zhang W, Greenberg N, and Zhang M. Maspin functions as tumor suppressor by increasing cell adhesion to extracellular matrix in prostate tumor cells. J Urol 169: 1157-1161, 2003
2. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, and Edwards BK (eds). SEER Cancer Statistics Review, 1975-2007, National Cancer Institute, Bethesda, MD. http://seer.cancer. gov/csr/1975-2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010
3. American Cancer Society. Cancer Facts and Figures. Atlanta, GA, USA. American Cancer Society, 2010
4. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, and Allgayer H. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136, 2008
5. Bhat-Nakshatri P, Wang G, Collins NR, Thomson MJ, Geistlinger TR, Carroll JS, Brown M, Hammond S, Srour EF, Liu Y, and Nakshatri H. Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res 37: 4850-4861, 2009
6. Böhm M, Sawicka K, Siebrasse JP, Brehmer-Fastnacht A, Peters R, and Klempnauer KH. The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA. Oncogene 22: 4905-4910, 2003
7. Brar SS, Corbin Z, Kennedy TP, Hemendinger R, Thornton L, Bommarius B, Arnold RS, Whorton AR, Sturrock AB, Huecksteadt TP, Quinn MT, Krenitsky K, Ardie KG, Lambeth JD, and Hoidal Jr. NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells. Am J Physiol Cell Physiol 285: C353-C369, 2003
8. Cheng Y, Liu X, Zhang S, Lin Y, Yang J, and Zhang C. MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol 47: 5-14, 2009
9. Cher ML, Biliran HR, Jr., Bhagat S, Meng Y, Che M, Lockett J, Abrams J, Fridman R, Zachareas M, and Sheng S. Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostatecancer bone metastasis. Proc Natl Acad Sci U S A 100: 7847-7852, 2003
10. Davis BN, Hilyard AC, Lagna G, and Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454: 56-61, 2008
11. Delworth M, Nishioka K, Pettaway C, Gutman M, Killion J, Voneschenbach A, and Fidler I. Systemic administration of 4-amidinoindanon-1-(2'-amidino)- hydrazone, a new inhibitor of s-adenosylmethionine decarboxylase, produces cytostasis of human prostate-cancer in athymic nude-mice. Int J Oncol 6: 293-299, 1995
12. Du J, Yang S, An D, Hu F, Yuan W, Zhai C, and Zhu T. BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1. Cell Res 19: 487-496, 2009
13. Fassan M, Pizzi M, Giacomelli L, Mescoli C, Ludwig K, Pucciarelli S, and Rugge M. PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis. Virchows Arch 458: 413-419, 2011
14. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, and Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283: 1026-1033, 2008
15. Fujita S, Ito T, Mizutani T, Minoguchi S, Yamamichi N, Sakurai K, and Iba H. miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J Mol Biol 378: 492-504, 2008
16. Gabriely G, Wurdinger T, Kesari S, Esau CC, Buchard J, Linsley PS, and Krichevsky AM. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 28: 5369-5380, 2008
17. Jajoo S, Mukherjea D, Watabe K, and Ramkumar V. Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity. Neoplasia 11: 1132-1145, 2009
18. Kumar B, Koul S, Khandrika L, Meacham RB, and Koul HK. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res 68: 1777-1785, 2008
19. Lagos-Quintana M, Rauhut R, Lendeckel W, and Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 294: 853-858, 2001
20. Lankat-Buttgereit B and Göke R. The tumour suppressor Pdcd4: Recent advances in the elucidation of function and regulation. Biol Cell 101: 309-317, 2009
21. Lassègue B and Clempus RE. Vascular NAD(P)H oxidases: Specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285: R277-R297, 2003
22. Lee C, Shevrin DH and Kozlowski JM. In vivo and in vitro approaches to study metastasis in human prostatic cancer. Cancer Metastasis Rev 12: 21-28, 1993
23. Li T, Li D, Sha J, Sun P, and Huang Y. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Commun 383: 280-285, 2009
24. Lin Y, Liu X, Cheng Y, Yang J, Huo Y, and Zhang C. Involvement of MicroRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells. J Biol Chem 284: 7903-7913, 2009
25. Liu J, Yin S, Reddy N, Spencer C, and Sheng S. Bax mediates the apoptosis-sensitizing effect of maspin. Cancer Res 64: 1703-1711, 2004
26. Löffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackermüller J, Kretzschmar AK, Burger R, Gramatzki M, Blumert C, Bauer K, Cvijic H, Ullmann AK, Stadler PF, and Horn F. Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of micro-RNA-21 through a highly conserved enhancer. Blood 110: 1330-1333, 2007
27. Lou Y, Yang X, Wang F, Cui Z, and Huang Y. MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein. Int J Mol Med 26: 819-827, 2010
28. Magenta A, Cencioni C, Fasanaro P, Zaccagnini G, Greco S, Sarra-Ferraris G, Antonini A, Martelli F, and Capogrossi MC. miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death Differ 18: 1628-1639, 2011
29. Mateescu B, Batista L, Cardon M, Gruosso T, de Feraudy Y, Mariani O, Nicolas A, Meyniel JP, Cottu P, Sastre-Garau X, and Mechta-Grigoriou F. miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med 17: 1627-1635, 2011
30. Meltzer PS. Cancer genomics: Small RNAs with big impacts. Nature 435: 745-746, 2005
31. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, and Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658, 2007
32. Mudduluru G, Medved F, Grobholz R, Jost C, Gruber A, Leupold JH, Post S, Jansen A, Colburn NH, and Allgayer H. Loss of programmed cell death 4 expression marks adenomacarcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer. Cancer 110: 1697-1707, 2007
33. O'Donnell BV, Tew DG, Jones OT, and England PJ. Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem J 290: 41-49, 1993
34. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, and Visakorpi T. MicroRNA expression profiling in prostate cancer. Cancer Res 67: 6130-6135, 2007
35. Ribas J, Ni X, Haffner M, Wentzel EA, Salmasi AH, Chowdhury WH, Kudrolli TA, Yegnasubramanian S, Luo J, Rodriguez R, Mendell JT, and Lupold SE. miR-21: An androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth. Cancer Res 69: 7165-7169, 2009
36. Sayed D, He M, Hong C, Gao S, Rane S, Yang Z, and Abdellatif M. MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J Biol Chem 285: 20281-20290, 2010
37. Seike M, Goto A, Okano T, Bowman ED, Schetter AJ, Horikawa I, Mathe EA, Jen J, Yang P, Sugimura H, Gemma A, Kudoh S, Croce CM, and Harris CC. MiR-21 is an EGFRregulated anti-apoptotic factor in lung cancer in neversmokers. Proc Natl Acad Sci U S A 106: 12085-12090, 2009
38. Selcuklu DS, Donoghue MTA, and Spillane S. miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 37: 918-925, 2009
39. Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJ, and Sager R. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci U S A 93: 11669-11674, 1996
40. Sheth S, Jajoo S, Kaur T, Mukherjea D, Sheehan K, Rybak LP, and Ramkumar V. Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway. PLoS One 7: E51655, 2012
41. Si ML, Zhu S, Wu H, Lu Z, Wu F, and Mo YY. miR-21-mediated tumor growth. Oncogene 26: 2799-2803, 2007
42. Siegel R, Naishadham D, and Jemal A. Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012
43. Sikka SC. Role of oxidative stress response elements and antioxidants in prostate cancer pathobiology and chemoprevention -A mechanistic approach. Curr Med Chem 10: 2679-2692, 2003
44. Simone NL, Soule BP, Ly D, Saleh AD, Savage JE, Degraff W, Cook J, Harris CC, Gius D, and Mitchell JB. Ionizing radiation-induced oxidative stress alters miRNA expression. PLoS One 4: E6377, 2009
45. Sun XY, Donald SP, and Phang JM. Testosterone and prostate specific antigen stimulate generation of reactive oxygen species in prostate cancer cells. Carcinogenesis 22: 1775-1780, 2001
46. Tahmatzopoulos T, Sheng S, and Kyprianou N. Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis. Oncogene 24: 5375-5383, 2005
47. Talotta F, Cimmino A, Matarazzo MR, Casalino L, De Vita G, D'Esposito M, Di Lauro R, and Verde P. An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. Oncogene 28: 73-84, 2009
48. Thulasingam S, Massilamany C, Gangaplara A, Dai H, Yarbaeva S, Subramaniam S, Riethoven JJ, Eudy J, Lou M, and Reddy J. miR-27b*, an oxidative stress-responsive microRNA modulates nuclear factor-kB pathway in RAW 264.7 cells. Mol Cell Biochem 352: 181-188, 2011
49. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, and Croce CM. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103: 2257-2261, 2006
50. Wang K and Li PF. Foxo3a regulates apoptosis by negatively targeting miR-21. J Biol Chem 285: 16958-16966, 2010
51. Wickramasinghe NS,Manavalan TT, Dougherty SM, Riggs KA, Li Y, and Klinge CM. Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res 37: 2584-2595, 2009
52. Yang HS, Cho MH, Zakowicz H, Hegamyer G, Sonenberg N, and Colburn NH. A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol Cell Biol 24: 3894-3906, 2004
53. Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S, Lockett SJ, Sonenberg N, and Colburn NH. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 23: 26-37, 2003
54. Yang HS, Knies JL, Stark C, and Colburn NH. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene 22: 3712-3720, 2003
55. Yin S, Li X, Meng Y, Finley RL, Jr., Sakr W, Yang H, Reddy N, and Sheng S. Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase. J Biol Chem 280: 34985-34996, 2005
56. Zhang B, Pan X, Cobb GP, and Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12, 2007
57. Zhang X, Ng WL, Wang P, Tian L, Werner E, Wang H, Doetsch P, and Wang Y. MicroRNA-21 modulates the levels of reactive oxygen species by targeting SOD3 and TNFa. Cancer Res 72: 4707-4713, 2012
58. Zhou R, Hu G, Gong AY, and Chen XM. Binding of NFkappaB p65 subunit to the promoter elements is involved in LPS-induced transactivation of miRNA genes in human biliary epithelial cells. Nucleic Acids Res 38: 3222-3232, 2010
59. Zhu S, Wu H, Wu F, Nie D, Sheng S, and Mo YY. Micro-RNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18: 350-359, 2008
60. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, and Sager R. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263: 526-529, 1994